Ginsenoside Rg3 Sensitizes Colorectal Cancer to Radiotherapy through Downregulation of Proliferative and Angiogenic Biomarkers

Figure 3

Detection of NF-κB by DNA binding in colorectal tumor tissue samples showing the inhibition of NF-κB by Rg3.